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ABSTRACT  Virtually all animal cells rapidly and specifically depress synthesis of new ~- and fl- 
tubulin polypeptides in response  to microtubule inhibitors that increase the pool of depoly- 
merized  subunits, or in  response  to direct elevation of the cellular tubulin subunit content 
through  microinjection  of exogenous tubulin subunits. Collectively,  these previous findings 
have documented the presence of an apparent eucaryotic, autoregulatory control mechanism 
that specifies  the level  of expression  of tubulin in cultured animal cells. Mechanistically, this 
regulation of tubulin  synthesis  is achieved through  modulation  of tubulin  mRNA  levels.  To 
dissect  further the  molecular  pathway that  underlies this autoregulatory  phenomenon,  we 
have now investigated whether enucleated cells still retain the requisite regulatory machinery 
with  which  to alter tubulin  synthetic  levels  in  response  to fluctuations  in the  pool  size of 
unpolymerized  tubulin  subunits.  Using  two-dimensional  gel  electrophoresis to analyze the 
patterns of new polypeptide synthesis, we have determined that such cytoplasts can indeed 
respond  to  drug-induced  microtubule  depolymerization  by  specific  repression  of  new  fl- 
tubulin synthesis.  Moreover, the response  of cytoplasts is, if anything, greater  in magnitude 
than that of whole cells. We conclude that autoregulatory control of fl-tubulin gene expression 
must derive principally, if not exclusively, from a cytoplasmic control mechanism  that modu- 
lates fl-tubulin  mRNA stability. For a-tubulin, although the response of cytoplasts after drug- 
induced microtubule depolymerization is quantitatively less dramatic than that of whole cells, 
at  least  part  of  the  regulatory  machinery  must  also  be  activated  through  a  cytoplasmic 
regulatory event. 
Microtubules,  which  are  composed principally of dimeric 
subunits of one ~- and fl-tubulin polypeptide, participate in a 
diverse spectrum of cellular functions including the establish- 
ment of programmed modifications of cell shape during mor- 
phogenesis, formation of mitotic and meiotic spindles,  and 
establishment of cilia-  and flagella-dependent cell motility. 
Given the  important functions of these dynamic arrays of 
microtubules whose protein components shuttle between the 
subunit  and  polymer  forms,  it  is  not  surprising  that  the 
synthesis of tubulin should be a closely regulated process. As 
initially reported by Ben Ze'ev et al. (1), marked alterations 
in the morphology of cultured animal cells after drug-induced 
microtubule depolymerization are accompanied by repression 
of new tubulin synthesis. What emerged less expectedly from 
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this work and from our own subsequent efforts (2-6) is the 
realization that the levels of tubulin synthesis are apparently 
established in these cells by an autoregulatory pathway closely 
linked to the pool size of unpolymerized subunits. 
Evidence in support of this autoregulatory model has ac- 
cumulated from a variety of experiments. Treatment of cells 
with  the  anti-microtubule drugs  colchicine or nocadozole, 
which induce microtubule depolymerization (see, e.g., refer- 
ences 7 and  8) and a  concomitant twofold increase in the 
pool of depolymerized subunits (9,  10), results in a specific 
(5-10-fold) repression of new tubulin synthesis (1, 4). On the 
other hand, treatment of cells with the anti-microtubule drug 
vinblastine, which induces not only microtubule depolymer- 
ization but also precipitation of the depolymerized subunits 
1941 (see, e.g., reference  11), yields a mild increase in new tubulin 
synthesis (1, 4). Moreover, treatment with taxol, a drug that 
stimulates polymerization and presumably lowers the pool of 
unpolymerized subunits to a negligible level (12, 13), induces 
an increase in new tubulin synthesis (4), which under some 
conditions can  be  quite  dramatic  (Pachter,  J.,  and  D.  W. 
Cleveland, unpublished observation). 
Further support for the autoregulatory model has emerged 
from elevation of intracellular tubulin content by direct  mi- 
croinjection of purified tubulin subunits to a level comparable 
to that which would be liberated by endogenous microtubule 
depolymerization.  After  such microinjection,  tubulin poly- 
peptide synthesis has been found to be rapidly and specifically 
repressed (5, 14). 
Although the  molecular  mechanism  through which  this 
apparent autoregulation is achieved has not yet been identi- 
fied, we have previously determined that the downregulation 
of tubulin synthesis in response to an increased pool size of 
free  subunits  is  accompanied  by  a  rapid  loss  of  tubulin 
mRNAs (4). Hence, regulation cannot be achieved through a 
reversible  RNA  sequestration mechanism.  In  addition,  the 
apparent rates of tubulin gene transcription in nuclei isolated 
from cells with normal or elevated pools of tubulin subunits 
have  been  found  to  be  indistinguishable (2).  This  finding 
suggests  either that transcription is not the principal level at 
which  control of tubulin synthesis is  exercised  or that the 
isolated nuclei do not faithfully mirror the in vivo situation, 
presumably as the result of loss of some necessary regulatory 
factor.  Thus, although the sum of the present data points to 
a relatively novel autoregulatory control mechanism  for es- 
tablishing tubulin synthetic levels, it remains unclear whether 
regulation is achieved through a nuclear process that involves 
RNA transcription, RNA processing, and/or RNA transport 
or, alternatively, through a cytoplasmic event that establishes 
tubulin mRNA stability. 
To dissect further the precise molecular events that underlie 
tubulin autoregulation, we  have  now sought to  determine 
whether enucleated cells retain the ability to respond to mi- 
crotubule depolymerization by specific inhibition of new tub- 
ulin  synthesis.  Under  conditions where  >95%  of cells  are 
enucleated, we report that for ~-tubulin the response of these 
cytoplast preparations  is,  if anything, greater  than  that of 
whole cells.  These data indicate that autoregulatory control 
of/~-tubulin gene expression must derive principally, if not 
exclusively, from a cytoplasmic control mechanism that mod- 
ulates #otubulin mRNA  stability.  Similarly, at least part of 
the regulatory machinery that modulates c~-tubulin synthesis 
must be localized in the cytoplasm since it is also retained in 
cytoplasts. 
MATERIALS AND  METHODS 
Cell  Culture:  Chinese hamster ovary (CHO)  ~ cells  were grown in 
Dulbecco's modified Eagle's medium (4,500 mg/liter glucose,  Gibco Labora- 
tories Inc., Grand Island, NY) supplemented with 10% fetal calf serum (Gibco 
Laboratories Inc.),  290 rag/liter glutamine (Gibco Laboratories Inc.), 40 mg/ 
liter proline (Sigma Chemical Co.,  St.  Louis,  MO),  I10  mg/liter sodium 
pyruvate (Sigma Chemical Co.) in a 5%  CO2 atmosphere at 37"C. Cells were 
routinely subcultured 1:10 every 3 d. 
Cytoplast  Preparation:  Cytoplasts  were prepared essentially  as de- 
scribed by Prescott et al. (l 5) but with a higher centrifugal force. Specifically, 
0.5-in. diameter glass coverslips were rinsed with acetone, dried, washed with 
67%  nitric acid,  33%  sulfuric acid for 2  h, extensively rinsed with tap and 
Abbreviation  used in this paper." CHO, Chinese hamster ovary. 
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distilled water,  and  stored  in  a  beaker  of ethanol.  Coverslips were handled 
individually with fine forceps. In a sterile hood, a coverslip was removed, excess 
ethanol was removed by aspiration, briefly flamed, and placed into a well of a 
4- or 24-well culture plate. Several drops of medium were added to the well to 
prevent the subsequently added cell suspension from being drawn beneath the 
coverslip. A dilute cell suspension was then  added and cells were allowed to 
grow for 24 to 48 h. The coverslip was carefully removed and placed cell-side 
down into a 15-ml Corex tube (Coming Glass Works, Coming, NY) containing 
-3 ml of 37"C media  supplemented  with 50  mM HEPES (Sigma Chemical 
Co.), pH 7.4, and 10 #g/ml of cytochalasin B (Sigma Chemical Co.). The tube 
was spun immediately  in a prewarmed,  fixed angle rotor (Sorvall ss34, E.  I. 
duPont de Nemours & Co., Inc., Sorvall Instruments Div., Newtown, CT) at 
6,000 g  (7,200 rpm) for 35  min.  The coverslip was carefully removed  and 
placed into 5 ml fresh medium without HEPES or cytochalasin B and allowed 
to recover for 30 to 60 min in the incubator before further use. This allows the 
cytoplasts to respread and assume a characteristic morphology. It is important 
that,  during  the  enucleation  procedure,  the  temperature  remain  near 37"C. 
Lower temperatures produce less efficient enucleation, whereas higher temper- 
atures induce heat shock in the cells. Typically, although 40-60%  of the ceils 
are  lost  from  the  coverslip, 95%  of the  remainder  are  enucleated.  In some 
experiments in which observation of both cells and cytoplasts was desired, the 
time or speed of centrifugation was slightly lowered to yield a lower efficiency 
of enucleation  and a higher number of remaining  cells/cytoplasts. Typically, 
for analysis of newly synthesized proteins, cytoplasts were incubated in methi- 
onine-free media supplemented with [3~S]methionine (~ 1,000 Ci/mmol, New 
England Nuclear, Boston, MA) to a final concentration  of 5 mCi/ml. Labeling 
was continued  for 40 rain and cytoplast proteins were then solubilized in SDS- 
gel sample buffer (16). 
In some cases, to ensure absolute purity of  the cytoplast preparations, labeled 
cytoplasts were individually removed from a coverslip using aspiration with a 
blunt-tipped glass needle attached to a micromanipulator.  Approximately 200 
cytoplasts were serially collected and then expelled directly into O'Farrell lysis 
buffer (17) to solubilize total cytoplast proteins. 
Autoradiography:  Cytoplasts  were prepared  as described  and  after 
recovery from enucleation  were rinsed with leucine-free medium.  Cytoplasts 
were labeled in multiwell plates containing 200-300 ul of leucine-free medium 
supplemented with 50 ~Ci of 2,3,4,5-[~H]leucine (120 Ci/mmol, ICN Chemical 
and Radioisotope Division, Irvine, CA) for 40 min. The labeling medium was 
drawn off, fresh medium was added, and the cells were further incubated  for 
20 rain.  The cells were fixed in 4% paraformaldehyde  in phosphate-buffered 
saline (PBS), pH 7.4, for 30 rain,  rinsed in PBS (two times for 5 rain), and 
further fixed and dehydrated  in methanol  at -20°C. The coverslips were air 
dried and affixed to microscope slides and allowed to dry. The slides were then 
dipped  in  nuclear  track  emulsion  (NTB2  emulsion,  Eastman  Kodak  Co., 
Rochester, NY). After drying, slides were wrapped individually in aluminum 
foil and exposed at 4'C for 1 to 4 d. Resultant grains over cytoplasts and cells 
were photographed on a Leitz inverted phase microscope with a long working 
distance, 40x phase objective and an Olympus OM2 camera with automatic 
exposure meter. 
Immuoofluorescence:  For tubulin  immunofluorescence,  coverslips 
with cytoplasts were placed in a microtubule-stabilizing buffer (4 M glycerol, 
l0 mM EGTA,  1 mM MgCl, 25 mM PIPES, pH 6.9) containing 0.1% Triton 
X-100 for 5 min, the same microtubule stabilizing buffer with 0.5% Triton  X- 
100  for 2 min, and finally into  the stabilizing buffer alone  for 2  min.  The 
coverslips were then placed into absolute methanol  at -20"C for 5 rain.  The 
coverslips were rehydrated in PBS for l min, and 20-25 ~l of a  1:200 dilution 
of an a-tubulin-specific  monoclonal  antibody  (DMIA, a gift from  Stephen 
Blose, Cold  Spring  Harbor Laboratories)  was added  for  I  h  at  37"C. The 
coverslips were washed twice for 5 min in excess PBS at 37"C. About 25 ~l of 
a  1:50 dilution  of fluoroscein-labeled goat anti-mouse IgG's (Cappel Labora- 
tories, Cochranville, PA) was then added and allowed to incubate for 40 min. 
The coverslips were washed (two times for 5 min at 37"C with PBS), dipped in 
distilled  water  to  remove  remaining  salts, and  air  dried.  Coverslips  were 
mounted in 90% glycerol, 10%  PBS, 5% wt/vol propyl gallate. Immunofluo- 
rescence microscopy was performed  on a Leitz Ortholux  II equipped with a 
100-W mercury light source for epifluorescence illuminization,  Zeiss 63 x  1.4 
numerical  aperture  oil immersion objective and Leitz H2 cube. Photomicro- 
graphs were recorded with a Leitz Vario-Orthomat  camera on Kodak  Tri-X 
pan film and developed at 400 ASA. 
Two-Dimensional Uectrophoresis:  Two-dimensional gel electro- 
phoresis was performed essentially as described (17) except that the ampholyte 
mixture was l:l:l  of pH 5-5.5,  pH 5-7,  pH 3-10 (Serva Fine Biochemicals 
Inc., Garden  City  Park,  NY)  for a  final ampholyte  concentration  of 2.4%. 
Samples initially solubilized in SDS-gel sample buffer were diluted into O'Far- 
rell lysis buffer (17) to which additional  urea was then added to bring the final 
concentration  back to 9.5  M.  Second-dimension  electrophoresis was carried out using 8.5% polyacrylamide gels as described previously (17). Radioactively 
labeled proteins were visualized by fluorography (l 8) using Kodak XAR-2 film. 
Quantification of Two-Dimensional  Gel Autoradiographs: 
Autoradiographs  of two-dimensional gels were quantified with a Louts Associ- 
ates, Inc. (Westminster,  MD), video densitometry  system coupled to an IBM 
PC computer for analysis of the recorded density patterns.  This system uses a 
Dage video camera linked (DAGE-MT1 inc., Wabash, MI) to an IBM computer 
to divide each autoradiographic  image into a 256 x  256 array of pixels. Each 
pixel is then assigned by a digitizing board to one of 256 different transmission 
levels based upon the percent transmission  recorded for that pixel. 
Calibration of the system was usually achieved by polymerization of succes- 
sive 1.5-fold dilutions  of a [35S]labeled protein sample into distinct, horizontal 
layers of a polyacrylamide  slab gel. The resultant gel was then fluorographed 
(18), dried, and cut into vertical strips. Each strip thus contained  a series of 
rectangles  whose 3sS content was  known from the  original  labeled protein 
sample  dilutions.  The 35S  content  of each  rectangle was also confirmed  by 
excision of the appropriate  regions followed by scintillation  counting.  A cali- 
bration strip was then affixed adjacent to each fluorographed, two-dimensional 
gel pattern  to be analyzed, and the strip plus gel were exposed together on a 
single x-ray film. Because each calibration  rectangle on the strip contained  a 
known number of counts per minute,  by digitizing each  of the calibration 
rectangles on the autoradiograph,  a direct assignment of counts per minute to 
a given transmission level could be made for each rectangle. The resultant curve 
of transmission  level versus  counts per  minute  was  then  fitted by  linear 
regression (coefficient of regression > 0.98). This final curve was then used to 
calculate a counts per minute value for every transmission level. 
Individual polypeptide spots on a digitized autoradiogram  were then quan- 
tified by defining the perimeter of each spot (using a touch sensitive pad). Each 
pixel  within  the  perimeter  was converted  into counts per minute,  and  the 
counts per minute were summed to yield a final value for counts within each 
spot. 
Because each  autoradiogram  to be  quantified  in  this  manner contained 
internal  standards  for number of counts per minute,  corrections  for the film 
response were automatically  incorporated. 
For direct  comparison of quantified  autoradiograms  of cells or cytoplasts 
incubated with different anti-microtubule  drugs, it was important to correct for 
any  errors  introduced  by  analysis  of autoradiographs  containing  different 
numbers of total counts per minute and/or exposed to different relative levels. 
Such corrections  were made by quantifying  (in addition  to quantification  of 
the corresponding  tubulin polypeptides)  14  nontubulin polypeptide  spots. A 
scaling factor for comparison of  the two different exposures was then calculated 
by a least squares fitting of the quantified  values for each of these 14 polypep- 
tides on the two different images. (In all cases, correlation coefficients exceeded 
0.97.) For direct comparison of two gels, all values for the 14 polypeptides and 
for the tubulin polypeptides were then scaled according to this calculated scaling 
factor. 
RESULTS 
Specific Repression of o~- and fl-Tubulin Synthesis 
in Whole CHO Cells As the Result of Drug- 
induced Microtubule Depolymerization 
All animal  cells investigated  to date have  been  found to 
respond to colchicine-induced microtubule depolymerization 
with  a  repression  of new  tubulin  polypeptide  synthesis  as 
measured  either  by  quantitative  immunoprecipitation  of 
newly synthesized 13-tubulin polypeptides (4) or by quantita- 
tion of tubulin mRNA levels (2, 4,  1  4). As previously  shown 
using two-dimensional gel  electrophoresis  of newly synthe- 
sized proteins in cultured mouse 3T6 cells (1), this depression 
in synthesis  is specific to tubulin polypeptides.  Both to dem- 
onstrate  the overall  specificity  of this drug-induced  response 
in an additional cell type and to provide a reference point for 
the pattern  of protein synthesis  in whole cells, we analyzed 
the proteins synthesized in CHO cells before and after a 3-h 
incubation in enough colchicine to induce rapid and complete 
microtubule  depolymerization.  After  pulse  labeling  with 
[35S]methionine, the patterns of polypeptide synthesis (shown 
in  Fig.  l, A  and  B)  were resolved by  two-dimensional gel 
electrophoresis.  As  is clear  in  the  figure,  not  only  was the 
overall  level  of protein  synthesis  unaffected  by  colchicine 
treatment  (as  we  had  reported  earlier  [4]),  but  with  two 
striking exceptions the level of synthesis  of individual poly- 
FIGURE  1  Specific repression of new tubulin synthesis in CliO cells in which endogenous microtubules have been depolymerized 
by treatment with colchicine. CHO cells were incubated in the presence or absence of 10 #M colchicine for 6  h to induce 
microtubule depolymerization.  At the end of drug treatment,  both aliquots of cells were labeled with [3SS]methionine for 30 min 
(with colchicine still  present  for drug-treated cells), and the samples were analyzed by two-dimensional electrophoresis.  (A) 
Pattern of protein synthesis in untreated, control cells; (B) pattern of protein synthesis in colchicine-treated cells. A, actin;/~,/~- 
tubulin; a, oL-tubulin; V, vimentin. Approximate molecular weights and isoelectric values are as follows: a-tubulin, 55,000, pl 5.2; 
fl-tubulin, 51,000, pl 5.0; vimentin, 58,000, pl 5.1; actin, 43,000, pl 5.3-5.4. 
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tubulin polypeptide is seen to change dramatically (at least at 
this level of exposure). To confirm this qualitative finding, we 
quantified the relative levels of synthesis of various polypep- 
tides using computer-assisted, two-dimensional video densi- 
tometry as detailed in Materials and Methods. (An example 
of such a digitized image corresponding to the autoradiograph 
in Fig. 6A is shown in Fig. 6 A'.) The analysis of these results 
demonstrated that the level of repression of synthesis of new 
a- and/3-tubulin polypeptides is approximately sevenfold for 
/3-tubulin and fivefold for a-tubulin. 
Determination of the Molecular Pathway 
Responsible for Tubulin Autoregulation:  Isolation 
and Characterization of Cytoplasts 
To begin to distinguish unambiguously whether the specific 
repression  of tubulin  synthesis  in  response to  an  elevated 
subunit pool was achieved through a cytoplasmic regulatory 
mechanism  or  through  a  nuclear  event,  we  exploited the 
finding of Prescott et al.  (15) that, after treatment of whole 
cells with the microfilament-disrupting drug cytochalasin B, 
nuclei may be removed from the more adherent cytoplasm 
by centrifugation.  Although  immediately after enucleation 
the morphology of the remaining enucleated cell fragments is 
highly aberrant (Fig.  2a),  respreading begins almost imme- 
diately after removal of cytochalasin B  and  appears to be 
complete within 30-60 min. Except for the lack of nuclei, the 
recovered cytoplasts look remarkably like cells, having visible 
organelles  and  well-defined  morphology as  shown  in  the 
phase-contrast micrograph in Fig. 2 b. 
Moreover, using indirect immunofluorescence with anti- 
tubulin antibodies, an extensive microtubule network is pres- 
ent in these cytoplasts (see for example Fig. 3 a). Morpholog- 
ically,  this array of cytoplast microtubules (which has been 
previously shown  to  extend at  least  in  part  from discrete 
microtubule initiation sites [ 19]) appears remarkably similar 
to the corresponding array in interphase whole cells. In addi- 
tion, as might be anticipated, this array is sensitive to treat- 
FIGURE  2  Rapid recovery and respreading of cytoplasts after enu- 
cleation. Cytoplasts were prepared by treatment with cytochalasin 
B and centrifugation as described in detail in Materials and Methods. 
The morphology of the resultant cytoplasts was then followed by 
phase-contrast microscopy. (a) Appearance of cytoplasts immedi- 
ately after enucleation. (b) Morphology of cytoplasts 60  rain after 
enucleation. Bar,  15/zm. x  360. 
1944  THE JOURNAL OF CELL BIOLOGY • VOLUME 101, 1985 
ment with colchicine. Fig. 3, a-d displays immunofluorescent 
micrographs of  cytoplasts that had been incubated for increas- 
ing times in colchicine. At this level of added drug, almost 
complete depolymerization of the  microtubule array is  in- 
duced within 90 min (Fig. 3 c). Thus, although a few micro- 
tubules in each cytoplast appear stable to colchicine-induced 
disassembly even after long exposure to the drug (Fig.  3,  c 
and d), colchicine treatment of cytoplasts results in the de- 
polymerization of  an extensive array of  microtubule polymers 
and thereby yields a  concomitant, apparent increase in the 
pool of unpolymerized subunits. 
Since our initial intent was to determine whether cytoplast 
preparations could respond to drug-induced microtubule de- 
polymerization with specific repression of new tubulin syn- 
thesis,  it was  important to ensure that cytoplasts could be 
prepared  substantially  free  from  contaminating  nucleated 
cells.  To this end, we  varied the  force and temperature of 
centrifugation until we identified conditions that consistently 
resulted in >95%  enucleation of CHO cells, where percent 
enucleation was determined by counting only the larger cy- 
toplasts (i.e.,  those that  were  about two-thirds cell  size  or 
larger).  Fig.  4a  displays  a  phase-contrast  micrograph  of a 
representative field containing over 100 cytoplasts. No nu- 
cleated cell is visible among all of these cell fragments. 
The apparent purity of cytoplast preparations is not due to 
inability to recognize remaining nuclei. For example, when 
present, cells that retain a nucleus are easily identifiable, as 
clearly demonstrated in the higher magnification, phase-con- 
trast micrograph in Fig. 4 b, in which a single nucleated cell 
(marked with the arrow) is found among a field of cytoplasts. 
Moreover,  the  possibility  that  a  substantial  population  of 
nucleated cells  can escape detection by phase-contrast mi- 
croscopy was eliminated by staining cytoplast preparations 
with the  DNA-binding dye ethidium bromide.  As  demon- 
strated in Fig. 4 c, nuclei are readily observable with fluores- 
cence optics after ethidium bromide staining.  In all instances, 
the calculated fraction of nuclei-containing cells determined 
either by phase morphology or by fluorescence was indistin- 
guishable. 
Finally, although it was clear that our cytoplast preparations 
were substantially free of nucleated cells, the possibility  re- 
mained  that  the  viability  of the  cytoplasts  was  impaired 
enough that a  significant fraction of the newly synthesized 
polypeptides  obtained  in  metabolic  labeling  experiments 
might actually derive from the contaminating nucleated cells. 
To test whether this possibility might be correct, we briefly 
incubated cytoplast preparations in  [3H]leucine  in order to 
label newly synthesized proteins. To detect whether the bulk 
of the radiolabel was incorporated into the cytoplasts or into 
whole cells, we then dipped the preparations in a photographic 
emulsion and subjected them to autoradiography. The results 
of  three independent experiments are shown in Fig. 5. In each 
part of the figure a solid arrow marks the location of a single 
nucleated cell in a cytoplast preparation. In each instance, the 
density of autoradiographic grains over cytoplasts and over 
the whole cells is qualitatively indistinguishable. The presence 
of grains over cytoplasts is due to true incorporation of [3n]- 
leucine into new polypeptides and not to nonspecific trapping 
of radiolabel since grains are localized only over cells  and 
cytoplasts, and an occasional (presumably nonviable) cyto- 
plast shows  no visible  grains at all  (open arrow in  Fig.  5). 
Overall, since cytoplasts comprise >95% of the total material 
in our cytoplast preparations and each cytoplast synthesizes FIGURE  3  Microtubule arrays in cytoplasts before and after treatment with colchicine as determined by indirect immunofluores- 
cence. After a 60-min recovery period after enucleation, cytoplasts were treated with- 10 ~M colchicine for varying times. Samples 
were fixed with formaldehyde after extraction with a detergent-containing, microtubule-stabilizing buffer and then incubated 
with a monoclonal antibody to a-tubulin. Finally, a fluorescein-labeled  goat anti-mouse secondary antibody was used to visualize 
bound tubulin antibody. Shown are the immunofluorescent patterns of microtubules observable after incubation in colchicine 
for (a) 0 min, (b) 30 min, (c) 90 min, and (d) 180 min. Bar, 15 #m. x  800. 
polypeptides at a rate comparable to that of whole cells, the 
vast majority of newly made proteins in  such preparations 
must derive from cytoplasts rather than from whole cells. 
Cytoplasts Respond  to Drug-induced 
Microtubule Depolymerization  by Specific 
Repression of New Tubulin Synthesis 
To determine whether cytoplast preparations retained the 
ability to respond to colchicine treatment with specific repres- 
sion of tubulin synthesis, newly synthesized proteins in cyto- 
plasts  were  briefly labeled  with  [~SS]methionine  and  then 
examined by two-dimensional gel electrophoresis. The syn- 
thetic patterns of control cytoplasts to which colchicine was 
not added are shown in Fig.  6, A, B, and  C,  for cytoplasts 
labeled at 0, 90, or 180 rain respectively, following a 60-min 
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respreading period post-enucleation. Keeping in  mind that 
the cytoplasts must lose the ability to synthesize new polypep- 
tides since RNAs lost through degradation cannot be replaced, 
the patterns of protein synthesis during this 3-h period after 
enucleation are remarkably constant. However, with increas- 
ing time after enucleation the relative levels of synthesis of 
several  proteins in  Fig.  6  decline in  amount (compare the 
patterns  from  non-drug-treated cytoplasts in  Fig.  6, A-C). 
This is not really surprising since such polypeptides can be 
inferred to be encoded by RNAs with inherently short (<2 h) 
half lives (at least in cytoplasts). 
Nonetheless,  despite  such  differences between  cells  and 
cytoplasts, by comparison of the synthetic patterns in control 
and colchicine-treated cytoplasts, it was still possible to deter- 
mine whether cytoplasts retained the requisite molecular ma- 
chinery for modulation  of tubulin  synthesis after drug-in- 
Regulation of Tubulin Synthesis  in Cytoplasts  1945 FIGURE  4  Demonstration that cytoplast preparations are virtually free of whole cells, a shows a phase-contrast micrograph of a 
large field of cytoplasts obtained by the standard enucleation protocol. Among the >100 cytoplasts there are no cells present 
with visible nuclei, b displays a higher magnification phase-contrast micrograph of a field of cytoplasts in which a single nucleated 
cell (arrow) is easily distinguished, c shows a fluorescence micrograph of a cytoplast preparation that was treated with ethidium 
bromide to stain nuclei present in residual cells. Again, a single nucleated cell is clearly detected. Bars, (a) 50 #m; (b and c)  15 
~m. (a) x  200; (b and c) x  730. 
duced  microtubule disassembly.  Through the  use  of [3ss]- 
methionine to pulse label newly synthesized polypeptides, the 
pattern of protein synthesis in control cytoplasts and in col- 
chicine-treated cytoplasts was investigated. Fig. 6B displays a 
two-dimensional gel  analysis of newly synthesized proteins 
from control cytoplasts 90  min  after respreading.  Fig.  6D 
displays the analogous pattern for cytoplasts to which colchi- 
cine was  added for 90  min  after respreading.  Qualitatively 
and  quantitatively,  the  patterns  are  very similar  with  the 
obvious exception that new/~-tubulin synthesis is markedly 
reduced in the colchicine-treated sample. Moreover, Fig. 6, C 
and E  show the corresponding patterns of newly synthesized 
polypeptides in control and drug-treated cytoplasts after 3 h 
of  drug-induced  microtubule  depolymerization;  selective 
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repression in synthesis of new/~-tubulin polypeptides is even 
more clearly visible in this example. 
To quantify these findings,  two-dimensional densitometry 
was  used to analyze each of the autoradiographs shown in 
Fig. 6, A-E. An example of  the digitized image corresponding 
to Fig. 6A is shown in Fig. 6A '. The resultant digitized values 
were scaled by linear regression to correct for the somewhat 
greater exposure of the colchicine-treated samples (Fig. 6, D 
and E) than of  the control cytoplasts (Fig. 6, B and C). These 
calculations indicated that the relative exposures of Fig. 6, A- 
E  were  1:0.79:0:83:1.30:1.92,  respectively. The areas corre- 
sponding  to  a-tubulin,  ~-tubulin,  vimentin,  and  13  other 
polypeptides were identified and quantified, and the results 
recorded in  Table  I.  As  is  evident in  the  table,  ~-tubulin FIGURE 5  Autoradiography of  [3H]leucine-labeled  preparations  reveals  the  level  of  protein  synthesis  to  be  comparable  in 
cytoplasts and in whole cells. Coverslips  from three independent enucleation experiments were labeled with [aH]leucine, dipped 
in a photographic emulsion, and the autoradiographs were developed. Each cytoplast sample shown includes a nucleated cell 
(indicated by the solid arrows).  The open arrow in the left panel identifies a cytoplast that has incorporated no leucine and is 
apparently nonviable. Bar, 15 #m. (Left to right) x  450; x  380; x  570. 
synthesis was depressed by ~ 12-fold in the drug-treated sam- 
ple.  When we compared this with  quantitative analyses of 
corresponding two-dimensional gels of proteins synthesized 
in whole cells (one example of which is displayed in Fig.  l) 
or with quantitative immunoprecipitations from whole cells 
(4),  we discovered that the magnitude of the decline in  fl- 
tubulin  synthesis upon  colchicine-induced microtubule de- 
polymerization is ~ 1.7-fold greater in cytoplasts than in whole 
cells. 
Similarly, when the autoradiographs from control and col- 
chicine-treated cytoplasts (compare Fig.  6, C and E, respec- 
tively) were corrected for the 2.3-fold greater exposure of the 
colchicine-treated sample (see above), synthesis of a-tubulin 
was  also  found  to  be  depressed  in  the  colchicine-treated 
cytoplasts. However, in  this instance the magnitude of the 
repression was quantitatively only two- to threefold, a level 
that is only ~50% that in whole cells. 
On the whole, colchicine-induced depression of new syn- 
thesis appeared reasonably specific to the tubulins since of the 
13  additional  polypeptide spots  analyzed,  synthesis of the 
tubulins was most markedly affected. Of the remaining poly- 
peptides quantified, only spot 5 deviated substantially (>45 %) 
in  value. We conclude that, although differences in  nontu- 
bulin polypeptides are observed, the principal effect of col- 
chicine-induced microtubule depolymerization in cytoplasts 
is repression of new tubulin synthesis. 
To determine whether this loss of new tubulin synthesis in 
cytoplasts could also be induced by treatment with additional 
anti-microtubule drugs, we analyzed the patterns of protein 
synthesis in cytoplasts incubated with the drugs nocodazole 
and taxol. Nocodazole, like colchicine, induces microtubule 
depolymerization and  increases the  pool of depolymerized 
subunits. Autoradiographs of the resultant two-dimensional 
gels are shown in Fig. 7, A and C for control and nocodazole- 
treated cytoplasts, respectively. Again, B-tubulin synthesis is 
specifically depressed  in  the  nocodazole-treated cytoplasts. 
Quantitatively, this repression was found to be threefold using 
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two-dimensional densitometry. This specific modulation of 
the fl-tubulin synthetic level is not simply due to disruption 
of  microtubule  function  by  all  anti-microtubule  drugs. 
Rather, consistent with the original autoregulatory  hypothesis, 
treatment of cytoplasts with the drug taxol, which induces 
additional microtubule polymerization and hence lowers the 
pool of depolymerized tubulin subunits, yields the pattern of 
new protein synthesis displayed in Fig. 7 B. In this instance, 
the level of new B-tubulin synthesis is mildly elevated with 
respect to other cellular proteins. This qualitative observation 
is also supported by densitometry, which reveals a 30% rela- 
tive increase in new fl-tubulin synthesis in taxol-treated cyto- 
plasts. However, even on longer exposures in which a-tubulin 
polypeptides were easily visible,  no significant change in a- 
tubulin levels was apparent in this experiment. 
Apparent Regulation of Tubulin Synthesis in 
Cytoplasts Cannot Be Due to Contaminating 
Nucleated Cells 
Although we have shown our cytoplast preparations to be 
substantially free of nucleated cells (Fig. 4) and further that 
the vast majority of labeled proteins are synthesized by cyto- 
plasts  rather  than  by  residual  nucleated  cells  (Fig.  5),  to 
remove any possible doubt as to the ability of cytoplasts to 
regulate tubulin synthesis in response to a drug-induced in- 
crease in the pool of depolymerized subunits, we have also 
used a protocol to collect individual cytoplasts. To do this, 
we have used an apparatus designed for microinjection of 
animal cells, but instead of fine-tipped glass needles to inject 
cells, we have used blunt-tipped needles to collect individual 
cytoplasts by aspiration. In the actual experiment, after label- 
ing  was  done  with  [35S]methionine,  ~200  cytoplasts were 
serially collected. At this point they were expelled into O'Far- 
rell lysis buffer (l 7), and the newly synthesized proteins were 
analyzed  by  two-dimensional  gel  electrophoresis.  Fig.  8A 
displays the resultant pattern for control cytoplasts, whereas 
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Colchicine 
Polypeptide  0 time  90 rain*  180 min  i 
fl-Tubulin  13.6  13.0  12.6 
~x-Tubu[in  2.9  4.9  4.9 
Vimentin  11.0  11.3  10.8 
1  4.7  4.7  4.7 
2  15.2  17.0  16.4 
3  4.0  4.2  4.1 
4  6.5  7.4  7.7 
5  13.1  14.9  14.9 
6  35.2  35.2  35.3 
7  1.4  2.0  1.8 
8  3.4  4.7  4.4 
9  4.4  4.6  4.4 
10  1.7  1.9  2.0 
11  10.3  11.9  ND 
12  2.0  2.4  2.3 
13  1.0  1.1  1.2 
+  Colchicine 
%  Difference between colchi- 
cine-treated and control** 
90 min I  180 min  i  90 min  180 min 
2.3  1.0  -465  -I ,I 60 
2.9  1.3  -68  -280 
12.2  10.1  +7  -7 
7.6  6.4  +38  +27 
21.6  16.2  +21  -1 
4.5  3.8  +7  -8 
7.9  7.5  +6  -3 
10.1  5.2  -44  -190 
24.4  24.8  -44  -42 
2.4  1.6  +17  -12 
4.6  5.3  +2  +17 
4.6  4.6  +0  +4 
2.3  3.1  +17  +35 
9.0  8.8  -32  ND 
2.9  3.2  +17  +28 
1.1  1.3  +0  +8 
* Quantification in arbitrary units of the autoradiographs shown in Fig. 6. 
* Data have been scaled by a factor of 1.27 to correct for level of exposure. 
i Data have been scaled by a factor of 1.2 to correct for level ot exposure. 
I Data have been scaled by a factor of 0.77 to correct for level of exposure. 
Data have been scaled by a factor of 0.52 to correct for level of exposure. 
** Calculated as ([final  value  -  initial value]/final value) x  100. 
Fig.  8B  shows  the  corresponding  pattern  from  cytoplasts 
treated for 6  h with colchicine. Clearly,  as we have already 
seen  in  Fig.  6  for  bulk  cytoplasts,  ~-tubulin  synthesis  is 
specifically repressed  as a consequence of drug-induced mi- 
crotubule depolymerization. Analysis of the patterns by den- 
sitometry reveals that this repression is approximately seven- 
fold. Unfortunately, in this experiment a-tubulin polypeptides 
were not sufficiently resolved from vimentin to permit quan- 
titation of a-tubulin synthetic levels. 
Apparent Regulation  of Yubulin Synthesis in 
Cytoplasts Is Due to a True Change in the Level 
of Tubulin Synthesis and Not to Instability of 
Tubulin Polypeptides  in Cytoplasts 
Because we used relatively long labeling times (40 min) to 
analyze the patterns of newly synthesized proteins in cyto- 
plasts, the observed decline in the amount of tubulin polypep- 
tides synthesized in colchicine- or nocadozole-treated cyto- 
plasts either could be the result of retention of the appropriate 
tubulin regulatory machinery in cytoplasts (particularly for 8- 
tubulin) or alternatively could be due to a markedly increased 
rate of tubulin polypeptide degradation induced in cytoplasts 
by treatment with these anti-microtubule drugs. To eliminate 
the latter  possibility, we sought to determine the half-life  of 
tubulin polypeptides in cytoplasts in both the presence and 
the absence of anti-microtubule drugs. To do this, we labeled 
cells  for  18  h  with  [35S]methionine before  preparation  as 
cytoplasts.  At  various  times  after  enucleation,  two-dimen- 
sional gels  were  used to examine the remaining prelabeled 
polypeptides. Autoradiographs of the resultant patterns are 
shown in Fig.  9  for equivalent numbers of cytoplasts taken 
immediately after enucleation (Fig.  9A), control cytoplasts 6 
h  after  enucleation (Fig.  9B),  or cytoplasts treated for 6  h 
with colchicine (Fig.  9 C). Clearly,  neither a- nor/~-tubulin 
polypeptides are lost relative  to other polypeptides over this 
6-h period. This qualitative finding was confirmed by quan- 
titative densitometry,  which revealed  no significant loss  of 
tubulin polypeptides over  the  6-h  period examined.  Thus, 
although an accurate half-life  of tubulin polypeptides in cy- 
toplasts cannot be determined from these data, it is clear that 
the half-life  is quite long as compared with the time scale of 
the cytoplast experiments presented in Figs. 6-8; hence, dif- 
ferential  polypeptide half-life  cannot explain the retention of 
tubulin regulation in cytoplasts. 
DISCUSSION 
Modulation of the level of new tubulin synthesis in response 
to alterations in the pool of unpolymerized tubulin subunits 
is a regulatory event that has been documented in all animal 
ceils  investigated.  Regulation  is  achieved  rapidly  through 
changes in cellular tubulin mRNA levels. A variety of previous 
FIGURE  6  Resolution of newly synthesized proteins in cytoplasts treated with colchicine reveals down  regulation of ~-tubulin 
synthesis. After recovery for 60 min, cytoplasts were incubated in the presence or absence of 10 ~M colchicine for increasing 
periods, and newly synthesized proteins were labeled with [35S]methionine for the final 40 min. The labeled proteins were then 
analyzed by two-dimensional gel electrophoresis. A,  B, and C,  respectively, represent synthesis patterns in untreated, control 
cytoplasts after 0, 90, or 180 min. D  and E represent synthesis patterns in cytoplasts treated with colchicine for 90 or 180 min, 
respectively. The circled spot in E represents an artifactual spot of 32p contamination, inadvertently introduced during gel drying. 
A,  actin;  ~,  fi-tubulin;  a,  a-tubulin;  V,  vimentin.  Spots  labeled  1-13  represent  reference  proteins  whose  intensities  were 
densitometered.  A'  is  a  black  and  white  photograph  of  a  color  image  representing the video display  of  the  digitized  two- 
dimensional image used to quantify polypeptides shown in A. 
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toplasts after microtubule depolymerization induced by colchicine. 
After  pulse  labeling with  [3SS]methionine,  -200  cytoplasts  were 
collected by aspiration  using a blunt-tipped glass needle attached 
to  a  micromanipulator.  The  cytoplasts  were  then  expelled  into 
O'Farrell lysis buffer (17) and the labeled  proteins were resolved 
by two-dimensional gel electrophoresis. A  fluorograph of the  re- 
sultant patterns is shown. (A) Pattern of protein synthesis in control 
cytoplasts;  (B) pattern of protein synthesis in cytoplasts treated  with 
6 h with colchicine. A, actin; B, B-tubulin; V, vimentin. 
FIGURE  7  Response of cytoplasts  to treatment with additional mi- 
crotubule inhibitors. The pattern of protein synthesis in cytoplasts 
was determined  by two-dimensional gel analysis of pulse-labeled 
proteins from (A) control cytoplasts,  (B) cytoplasts  incubated for 6 
h  in  10 /~M taxol, or  (C)  cytoplasts  incubated  for  6  h  in  10 /zM 
nocodazole. A  fluorograph of the  resultant patterns  is shown. A, 
actin;/3,-tubulin; V, vimentin. 
experimental approaches have attempted to identify the mo- 
lecular events responsible for this regulatory process. Initially, 
based upon the rough estimation of a 2-h half life of tubulin 
mRNAs in cells in which all new RNA synthesis was inhibited 
with actinomycin D, Ben Ze'ev et al. (1) proposed that such 
regulation  was modulated  by altered  rates of formation of 
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new tubulin RNAs, an hypothesis for which additional indi- 
rect  support  was  forthcoming  in  other  experiments  using 
actinomycin D  (3). However, serious question of the contri- 
bution  of transcriptional regulation was raised by measure- 
ment  of tubulin  transcription  rates in  nuclei  isolated  from 
control or colchicine-treated cells.  These experiments failed 
to find any detectable difference in tubulin gene transcription 
levels (2).  By preparing populations of enucleated cell frag- 
ments we have now demonstrated that most, if not all of the 
cellular machinery responsible for establishing B-tubulin syn- 
thetic rates is retained in enucleated cells. Since we have also 
shown  that  the  bulk  of the  proteins  synthesized  in  these 
cytoplast preparations derive from cytoplasts and  not  from 
the small proportion of remaining nucleated cells (Fig. 5 and 
8),  it is clear that the  original hypothesis of transcriptional 
regulation, which was based upon use of the pleotropic drug 
actinomycin D, is incorrect. 
At first thought, it may be somewhat surprising that cyto- 
plasts can retain such a regulatory mechanism. However, it is 
well known that cytoplasts are remarkably viable. For exam- 
ple, Albrecht-Buehler demonstrated that even very tiny frag- 
ments of enucleated  cells  remain  alive for at  least  8  h,  as 
judged  by ability to  produce and  move filopodia or ruffle 
membranes (20).  Similarly,  Karsenti  et  al.  (19)  noted  that 
regrown microtubule arrays remained intact and apparently 
normal for as long as  18  h  after enucleation.  With  this in 
mind, what may be more striking is that/~-tubulin regulation 
appears, if anything, to be more complete in the cytoplasts 
than in whole cells (compare data of Fig. 6 with those of Fig. 
l or with those of Fig. 2 of reference 4). Of course, this finding 
is expected for a cytoplasmic regulatory event that modulates 
tubulin  mRNA stability: in the absence of a  nuclear contri- 
bution of newly synthesized ~-tubulin RNAs, a reduction in 
cytoplasmic stability  will  yield  a  more  rapid  loss  of cyto- 
plasmic RNA content. 
However, given the results for ~-tubulin, the only modest 
cytoplasmic regulation of new a-tubulin synthesis is surpris- 
ing.  Either a-tubulin synthesis is not wholly controlled by a 
cytoplasmic mechanism similar to that for/~-tubulin or that 
regulatory machinery is not completely maintained in cyto- 
plasts. FIGURE 9  Determination of the stability of tubulin polypeptides in 
cytoplasts.  CHO cells were seeded onto each of three coverslips 
and the cells were labeled with [~SS]methionine for 18 h (in methi- 
onine-free  Dulbecco's  modified  Eagle's medium  supplemented 
with 10% fetal calf serum and with one-tenth the normal level of 
unlabeled methionine). Cytoplasts were then prepared from each 
slip, and the pattern of prelabeled polypeptides was examined by 
two-dimensional gel electrophoresis.  Shown  are the  patterns  of 
prelabeled polypeptides in  (A)  cytoplasts  examined immediately 
after enucleation, (B) control cytoplasts  examined 6  h after enu- 
cleation, and  (C) cytoplasts  incubated for 6  h with colchicine. A, 
actin; ~,/~-tubulin; ~, a-tubulin; V, vimentin. 
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Cytoplasmic control  of gene  expression has  been  docu- 
mented for a  variety of previously investigated systems, in- 
cluding the  programs  of tubulin  gene expression in  lower 
eucaryotes. Specifically,  Baker et al. (2 l) have deafly dem- 
onstrated that the programmed burst of tubulin synthesis in 
response to deflagellation in the algae Chlamydomonas rein- 
hardi results from a combination of transient transcriptional 
enhancement and altered tubulin mRNA stability.  Similarly, 
Schedl et al. (22) have demonstrated that tubulin expression 
in the synchronous cell cycle of Physarum is achieved in part 
by specific changes in tubulin mRNA stability.  In addition, 
in cultured animal cells a-tubulin synthesis has been shown 
to  be  modulated  apparently  through  a  nontranscriptional 
mechanism during differentiation of a  teratocarcinoma cell 
line (23). What distinguishes the present example from these 
others is the intriguing autoregulatory nature of the control 
event. Although it is not unexpected that such autoregulatory 
pathways must exist, very few other eucaryotic examples have 
yet been identified. Moreover, in the best studied of these (T 
antigen  encoded by SV40  [24]  and  the  70-kD  heat-shock 
protein [25]), the principal level of regulation has been doc- 
umented to be at the transcriptional level. Hence, cytoplasmic 
control of apparent autoregulation of tubulin synthesis rep- 
resents a relatively novel, if not altogether unexpected, path- 
way for control of expression of a eucaryotic gene. 
Moreover, in conjunction with a variety of previous results, 
the present data have also made it clear that the alteration in 
tubulin synthetic rates does not simply reflect an inherent cell 
cycle-dependent program of tubulin synthesis that is uncov- 
ered by drug-induced cell cycle disruption. This conclusion 
arises from four independent lines of  evidence. First, although 
cell  cycle control must be severely disrupted in  cytoplasts, 
regulation of ~-tubulin synthesis is maintained. Second, even 
in whole cells the maximum effect is seen within 3 h of drug 
addition,  a  time too  short to  yield a  substantial  cell cycle 
blockage in an initially unsynchronized culture. Third, col- 
chicine and nocadozole induce mitotically blocked cell pop- 
ulations that are essentially identical to that induced by vin- 
blastine, even though the effects on tubulin synthetic levels 
are  of opposite signs.  Fourth,  in  contrast to the  dramatic 
repression of tubulin synthesis induced by colchicine or no- 
codazole treatment, a  simple calculation using the reported 
threefold decline in the overall rate of protein synthesis during 
mitosis (26) coupled with the known twofold relative increase 
in  tubulin  synthesis at  mitosis  (27)  yields a  predicted 6% 
increase in the relative tubulin synthetic rate after a 3-h drug- 
induced mitotic arrest for cells with a doubling time of 16 h. 
But to what physiological end is this cytoplasmic mecha- 
nism that regulates tubulin synthesis in an apparent, autoreg- 
ulatory manner used? Although there are as yet no experi- 
mental data that directly approach this most important ques- 
tion, it is clear that intracellular tubulin polymer levels are 
tied  to  the  subunit  levels  in  some  complicated  way  that 
involves microtubule initiation sites and microtubule-associ- 
ated proteins. More specifically, as first described by Kirschner 
(28), if the free subunit concentration is maintained between 
Cc  ÷ (the critical concentration for growth off of a nucleated 
microtubule whose free end is distal to the centrosome) and 
C¢  s (the subunit concentration at steady state with a  micro- 
tubule with both ends free), then nonnucleated polymers will 
be unstable at the same time that nucleated polymers continue 
to assemble.  Added to this  complexity is the potential for 
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and Kirschner (29, 30). As a result of this phenomenon even 
a population of nucleated microtubules may consist of poly- 
mers that are slowly elongating at the same time that others 
in the same population are rapidly disassembling.  Consider- 
ation of all of these potential effects suggests that even though 
the assembly process could be self-buffering with a final steady 
state  level  of subunits  of Cc  + for a  system  with  nucleated 
polymers  or Ccs  for a  system  without  nucleated  polymers, 
autogenous regulation  of tubulin  subunit  levels may act to 
augment or even to bypass this control. (Indeed, there is no 
direct evidence that microtubules are in fact at steady state 
with subunit levels in vivo.) In any event, given the complexity 
of the overall assembly process, it seems very likely that in 
concert  with  other  regulatory  events  strict  autoregulatory 
control of new tubulin synthesis is used to control carefully 
the extent and pattern of in vivo microtubule assembly. 
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